BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol 2019;26:27-40. [PMID: 30300457 DOI: 10.1111/ene.13819] [Cited by in Crossref: 264] [Cited by in F6Publishing: 221] [Article Influence: 66.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahroum N, Alghory A, Kiyak Z, Alwani A, Seida R, Alrais M, Shoenfeld Y. Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun 2022;126:102778. [PMID: 34883281 DOI: 10.1016/j.jaut.2021.102778] [Reference Citation Analysis]
2 Morales-Ruiz V, Juárez-Vaquera VH, Rosetti-Sciutto M, Sánchez-Muñoz F, Adalid-Peralta L. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis. Autoimmun Rev 2021;21:103019. [PMID: 34920107 DOI: 10.1016/j.autrev.2021.103019] [Reference Citation Analysis]
3 Seo Y, Jin C, Cho SY, Park SU, Jung WS, Moon SK, Park JM, Ko CN, Cho KH, Kwon S. Current Utilization and Research Status of Traditional East Asian Herbal Medicine Treatment for Multiple Sclerosis: A Scoping Review. Front Neurol 2021;12:710769. [PMID: 34733228 DOI: 10.3389/fneur.2021.710769] [Reference Citation Analysis]
4 Cao Q, Zheng C, Xie Z, Liu L, Zhu J, Jin T. The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)2D3. Journal of Neuroimmunology 2020;338:577079. [DOI: 10.1016/j.jneuroim.2019.577079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Gröger V, Emmer A, Staege MS, Cynis H. Endogenous Retroviruses in Nervous System Disorders. Pharmaceuticals (Basel) 2021;14:70. [PMID: 33467098 DOI: 10.3390/ph14010070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Bühring J, Hecker M, Fitzner B, Zettl UK. Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis. Aging Dis 2021;12:1272-86. [PMID: 34341708 DOI: 10.14336/AD.2021.0106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kohl HM, Castillo AR, Ochoa-Repáraz J. The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? Diseases 2020;8:E33. [PMID: 32872621 DOI: 10.3390/diseases8030033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Kolić I, Stojković L, Stankovic A, Stefanović M, Dinčić E, Zivkovic M. Association study of rs7799039, rs1137101 and rs8192678 gene variants with disease susceptibility/severity and corresponding LEP, LEPR and PGC1A gene expression in multiple sclerosis. Gene 2021;774:145422. [PMID: 33450350 DOI: 10.1016/j.gene.2021.145422] [Reference Citation Analysis]
9 Kuchling J, Paul F. Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Front Neurol 2020;11:450. [PMID: 32625158 DOI: 10.3389/fneur.2020.00450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
10 Varvatsi D, Richter J, Tryfonos C, Pantzaris M, Christodoulou C. Association of Epstein-Barr virus latently expressed genes with multiple sclerosis. Mult Scler Relat Disord 2021;52:103008. [PMID: 34010765 DOI: 10.1016/j.msard.2021.103008] [Reference Citation Analysis]
11 Andreu-Caravaca L, Ramos-Campo DJ, Abellán-Aynés O, Rubio-Arias JÁ. Movement Velocity as A Measure of Exercise Intensity in Persons with Multiple Sclerosis: A Validity Study. J Clin Med 2020;9:E2458. [PMID: 32751943 DOI: 10.3390/jcm9082458] [Reference Citation Analysis]
12 Altmann P, Hinterberger W, Leutmezer F, Ponleitner M, Monschein T, Zrzavy T, Zulehner G, Kornek B, Lanzenberger R, Berek K, Rommer PS, Berger T, Bsteh G. The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study. JMIR Res Protoc 2021;10:e25011. [PMID: 33960949 DOI: 10.2196/25011] [Reference Citation Analysis]
13 Storm CS, Kia DA, Almramhi M, Wood NW. Using Mendelian randomization to understand and develop treatments for neurodegenerative disease. Brain Commun 2020;2:fcaa031. [PMID: 32954289 DOI: 10.1093/braincomms/fcaa031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 van Eijk M, Aerts JMFG. The Unique Phenotype of Lipid-Laden Macrophages. Int J Mol Sci 2021;22:4039. [PMID: 33919858 DOI: 10.3390/ijms22084039] [Reference Citation Analysis]
15 Moosavi E, Rafiei A, Yazdani Y, Eslami M, Saeedi M. Association of serum levels and receptor genes BsmI, TaqI and FokI polymorphisms of vitamin D with the severity of multiple sclerosis. J Clin Neurosci 2021;84:75-81. [PMID: 33485603 DOI: 10.1016/j.jocn.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kołtuniuk A, Kazimierska-Zając M, Cisek K, Chojdak-Łukasiewicz J. The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients. Psychol Res Behav Manag 2021;14:805-15. [PMID: 34177278 DOI: 10.2147/PRBM.S310664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Patel C, Zagon IS, Pearce-Clawson M, McLaughlin PJ. Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 2021. [PMID: 34821408 DOI: 10.1002/jnr.24983] [Reference Citation Analysis]
18 Janitschke D, Lauer AA, Bachmann CM, Grimm HS, Hartmann T, Grimm MOW. Methylxanthines and Neurodegenerative Diseases: An Update. Nutrients 2021;13:803. [PMID: 33671099 DOI: 10.3390/nu13030803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Petruzzo M, Reia A, Maniscalco GT, Luiso F, Lanzillo R, Russo CV, Carotenuto A, Allegorico L, Palladino R, Brescia Morra V, Moccia M. The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis. Eur J Neurol 2021;28:893-900. [PMID: 33091222 DOI: 10.1111/ene.14608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Posso-Osorio I, Tobón GJ, Cañas CA. Human endogenous retroviruses (HERV) and non-HERV viruses incorporated into the human genome and their role in the development of autoimmune diseases. J Transl Autoimmun 2021;4:100137. [PMID: 34917914 DOI: 10.1016/j.jtauto.2021.100137] [Reference Citation Analysis]
21 Zhang H, Zhang J, Li C, Sweeney EM, Spincemaille P, Nguyen TD, Gauthier SA, Wang Y, Marcille M. ALL-Net: Anatomical information lesion-wise loss function integrated into neural network for multiple sclerosis lesion segmentation. Neuroimage Clin 2021;32:102854. [PMID: 34666289 DOI: 10.1016/j.nicl.2021.102854] [Reference Citation Analysis]
22 Yan J, McCombe PA, Pender MP, Greer JM. Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation. J Clin Med 2020;9:E2534. [PMID: 32781504 DOI: 10.3390/jcm9082534] [Reference Citation Analysis]
23 Baker D, Hadjicharalambous C, Gnanapavan S, Giovannoni G. Can rheumatologists stop causing demyelinating disease? Mult Scler Relat Disord 2021;53:103057. [PMID: 34126373 DOI: 10.1016/j.msard.2021.103057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Kolić I, Stojković L, Dinčić E, Jovanović I, Stanković A, Živković M. Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis. Journal of Neuroimmunology 2020;338:577090. [DOI: 10.1016/j.jneuroim.2019.577090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 de Oliveira LRC, Mimura LAN, Fraga-Silva TFC, Ishikawa LLW, Fernandes AAH, Zorzella-Pezavento SFG, Sartori A. Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation. Front Pharmacol 2020;11:161. [PMID: 32226379 DOI: 10.3389/fphar.2020.00161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
27 Zhu Y, Huang M, Zhao Y, Pei Y, Wang Y, Wang L, He T, Zhou F, Zeng X. Local functional connectivity of patients with acute and remitting multiple sclerosis: A Kendall's coefficient of concordance- and coherence-regional homogeneity study. Medicine (Baltimore) 2020;99:e22860. [PMID: 33120824 DOI: 10.1097/MD.0000000000022860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ahmad I, Wergeland S, Oveland E, Bø L. A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination. PLoS One 2021;16:e0256155. [PMID: 34437581 DOI: 10.1371/journal.pone.0256155] [Reference Citation Analysis]
29 Tripathi MK, Kartawy M, Amal H. The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biol 2020;34:101567. [PMID: 32464501 DOI: 10.1016/j.redox.2020.101567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
30 Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB. Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. Mult Scler Relat Disord 2021;48:102691. [PMID: 33360174 DOI: 10.1016/j.msard.2020.102691] [Reference Citation Analysis]
31 Al-Senani M, Al-Salti A, Nandhagopal R, Al-Zakwani I, Alkhabouri J, Elyas ME, Gujjar AR, Al-Asmi A. Epidemiology of multiple sclerosis in the Sultanate of Oman: A hospital based study. Mult Scler Relat Disord 2021;53:103034. [PMID: 34087687 DOI: 10.1016/j.msard.2021.103034] [Reference Citation Analysis]
32 Swart ECS, Mager D, Parekh N, Heyman RA, Henderson R, Munshi K, Bridges G, Good CB. Infection incidence and management in multiple sclerosis patients after initiating disease-modifying therapy. Mult Scler Relat Disord 2021;56:103285. [PMID: 34662846 DOI: 10.1016/j.msard.2021.103285] [Reference Citation Analysis]
33 De Silvestri A, Capittini C, Mallucci G, Bergamaschi R, Rebuffi C, Pasi A, Martinetti M, Tinelli C. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis. Dis Markers 2019;2019:1409069. [PMID: 31781296 DOI: 10.1155/2019/1409069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
34 Frahm N, Hecker M, Zettl UK. Polypharmacy among patients with multiple sclerosis: a qualitative systematic review. Expert Opinion on Drug Safety 2020;19:139-45. [DOI: 10.1080/14740338.2020.1720646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
35 Pellizoni FP, Leite AZ, Rodrigues NC, Ubaiz MJ, Gonzaga MI, Takaoka NNC, Mariano VS, Omori WP, Pinheiro DG, Matheucci Junior E, Gomes E, de Oliveira GLV. Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis. Int J Environ Res Public Health 2021;18:4621. [PMID: 33925359 DOI: 10.3390/ijerph18094621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tavassolifar MJ, Moghadasi AN, Esmaeili B, Sadatpour O, Vodjgani M, Izad M. Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients. Oxid Med Cell Longev 2020;2020:8860813. [PMID: 33354282 DOI: 10.1155/2020/8860813] [Reference Citation Analysis]
37 Giussani P, Prinetti A, Tringali C. The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders. J Neurochem 2021;156:403-14. [PMID: 33448358 DOI: 10.1111/jnc.15133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Jongen PJ, Ter Veen G, Lemmens W, Donders R, van Noort E, Zeinstra E. The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment. J Med Internet Res 2020;22:e14297. [PMID: 32149713 DOI: 10.2196/14297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Soltanmoradi S, Tavakolpour V, Moghadasi AN, Kouhkan F. Expression analysis of NF-κB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients. J Neuroimmunol 2021;356:577602. [PMID: 33979709 DOI: 10.1016/j.jneuroim.2021.577602] [Reference Citation Analysis]
40 Bernitsas E, Kopinsky H, Lichtman-Mikol S, Razmjou S, Santiago-Martinez C, Yarraguntla K, Bao F. Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study. J Neuroimaging 2021;31:379-87. [PMID: 33368776 DOI: 10.1111/jon.12824] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Starčević Čizmarević N, Ćurko-Cofek B, Barac-Latas V, Peterlin B, Ristić S. Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis. Biomed Rep 2022;16:12. [PMID: 34987796 DOI: 10.3892/br.2021.1495] [Reference Citation Analysis]
42 Cai M, Zhang Y, Zheng Y, Fang W, Ding M. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis. Multiple Sclerosis and Related Disorders 2019;32:41-5. [DOI: 10.1016/j.msard.2019.04.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
43 Jin W, Leitzen E, Goebbels S, Nave KA, Baumgärtner W, Hansmann F. Comparison of Theiler's Murine Encephalomyelitis Virus Induced Spinal Cord and Peripheral Nerve Lesions Following Intracerebral and Intraspinal Infection. Int J Mol Sci 2019;20:E5134. [PMID: 31623261 DOI: 10.3390/ijms20205134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Bribiesca-Contreras E, García-Estrada C, Gómez-Figueroa E, Zertuche-Ortuño L, Rodríguez-Rivas R, Marcín-Sierra M, Delgado-Niño M, Rivas-Alonso V, Corona-Vázquez T, Flores-Rivera J. Impact of rituximab in Mexican patients with Multiple Sclerosis-A single-center retrospective study. Mult Scler Relat Disord 2022;58:103485. [PMID: 35042092 DOI: 10.1016/j.msard.2021.103485] [Reference Citation Analysis]
45 Mousavi SR, Tahmasebivand M, Khorrami M, Ayromlou H, Khalili SK, Khorvash F, Rikhtegar R, Khademi B, Bahmanpour Z, Emamalizadeh B. Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients. Mult Scler Relat Disord 2020;44:102264. [PMID: 32554287 DOI: 10.1016/j.msard.2020.102264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Hassanshahi G, Roohi MA, Esmaeili SA, Pourghadamyari H, Nosratabadi R. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients. Cytokine 2021;148:155706. [PMID: 34583254 DOI: 10.1016/j.cyto.2021.155706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Cheng YW, Chen HC, Lyu SY, Li YF, Lu CC. Progressive white matter disease in Sjögren's syndrome. Rheumatology (Oxford) 2021;60:e146-8. [PMID: 33221875 DOI: 10.1093/rheumatology/keaa628] [Reference Citation Analysis]
48 Song S, Guo R, Mehmood A, Zhang L, Yin B, Yuan C, Zhang H, Guo L, Li B. Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway. CNS Neurosci Ther 2022. [PMID: 34985189 DOI: 10.1111/cns.13791] [Reference Citation Analysis]
49 Zhang E, Tian X, Li R, Chen C, Li M, Ma L, Wei R, Zhou Y, Cui Y. Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials. Orphanet J Rare Dis 2021;16:87. [PMID: 33588903 DOI: 10.1186/s13023-021-01694-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Newland P, Miller R, Bettencourt BA, Hendricks-Ferguson V. Pilot Study of Videos to Deliver Mindfulness-Based Art Therapy for Adults With Multiple Sclerosis. J Neurosci Nurs 2020;52:E19-23. [PMID: 33156593 DOI: 10.1097/JNN.0000000000000547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Motolese F, Rossi M, Albergo G, Stelitano D, Villanova M, Di Lazzaro V, Capone F. The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis. Front Neurol 2020;11:580507. [PMID: 33193033 DOI: 10.3389/fneur.2020.580507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
52 Khatri DK, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S, Singh SB. Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Curr Res Pharmacol Drug Discov 2021;2:100022. [PMID: 34909657 DOI: 10.1016/j.crphar.2021.100022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Bernstein HG, Keilhoff G, Dobrowolny H, Lendeckel U, Steiner J. From putative brain tumor marker to high cognitive abilities: Emerging roles of a disintegrin and metalloprotease (ADAM) 12 in the brain. J Chem Neuroanat 2020;109:101846. [PMID: 32622867 DOI: 10.1016/j.jchemneu.2020.101846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Lu XY, Han B, Deng X, Deng SY, Zhang YY, Shen PX, Hui T, Chen RH, Li X, Zhang Y. Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota. Gut Microbes 2020;12:1857515. [PMID: 33382357 DOI: 10.1080/19490976.2020.1857515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
55 Habib R, Ocklenburg S, Hoffjan S, Haghikia A, Epplen JT, Arning L. Association between shorter leukocyte telomeres and multiple sclerosis. J Neuroimmunol 2020;341:577187. [PMID: 32050150 DOI: 10.1016/j.jneuroim.2020.577187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
56 Zhuravleva MV, Davydovskaya MV, Luchinina EV, Shelekhova TV, Kurguzova DO, Serebrova SY. [Comparison of the clinical benefits of second-line drugs modifying the course of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:148-53. [PMID: 32929938 DOI: 10.17116/jnevro2020120081148] [Reference Citation Analysis]
57 Illiano P, Brambilla R, Parolini C. The mutual interplay of gut microbiota, diet and human disease. FEBS J 2019;287:833-55. [DOI: 10.1111/febs.15217] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
58 Moser T, Akgün K, Proschmann U, Sellner J, Ziemssen T. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun Rev 2020;19:102647. [PMID: 32801039 DOI: 10.1016/j.autrev.2020.102647] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
59 Covello F, Ruoppolo G, Carissimo C, Zumbo G, Ferrara C, Polimeni A, Vozza I. Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life. Int J Environ Res Public Health 2020;17:E3979. [PMID: 32512730 DOI: 10.3390/ijerph17113979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Kaufmann M, Puhan MA, Kuhle J, Yaldizli Ö, Magnusson T, Kamm CP, Calabrese P, von Wyl V. A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis. Front Neurol 2019;10:953. [PMID: 31555205 DOI: 10.3389/fneur.2019.00953] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
61 Cerexhe L, Easton C, Macdonald E, Renfrew L, Sculthorpe N. Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord 2021;57:103454. [PMID: 34915317 DOI: 10.1016/j.msard.2021.103454] [Reference Citation Analysis]
62 Frahm N, Hecker M, Langhorst SE, Mashhadiakbar P, Haker MC, Zettl UK. The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis. Ther Adv Neurol Disord 2020;13:1756286420969501. [PMID: 33425014 DOI: 10.1177/1756286420969501] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Russell RD, Black LJ, Pham NM, Begley A. The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 2020;44:102171. [PMID: 32554283 DOI: 10.1016/j.msard.2020.102171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Chacko G, Patel S, Galor A, Kumar N. Heat Exposure and Multiple Sclerosis-A Regional and Temporal Analysis. Int J Environ Res Public Health 2021;18:5962. [PMID: 34199394 DOI: 10.3390/ijerph18115962] [Reference Citation Analysis]
65 Agnello L, Lo Sasso B, Salemi G, Altavilla P, Pappalardo EM, Caldarella R, Meli F, Scazzone C, Bivona G, Ciaccio M. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis. Laboratory Medicine 2020;51:402-7. [DOI: 10.1093/labmed/lmz073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Bergqvist C, Hemery F, Ferkal S, Wolkenstein P. Neurofibromatosis I and multiple sclerosis. Orphanet J Rare Dis 2020;15:186. [PMID: 32664938 DOI: 10.1186/s13023-020-01463-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Mimpen M, Smolders J, Hupperts R, Damoiseaux J. Natural killer cells in multiple sclerosis: A review. Immunol Lett 2020;222:1-11. [PMID: 32113900 DOI: 10.1016/j.imlet.2020.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
68 Learmonth YC, Motl RW. Exercise Training for Multiple Sclerosis: A Narrative Review of History, Benefits, Safety, Guidelines, and Promotion. Int J Environ Res Public Health 2021;18:13245. [PMID: 34948854 DOI: 10.3390/ijerph182413245] [Reference Citation Analysis]
69 Naseri A, Forghani N, Sadigh-Eteghad S, Shanehbandi D, Asadi M, Nasiri E, Talebi M. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler Relat Disord 2021;57:103432. [PMID: 34922253 DOI: 10.1016/j.msard.2021.103432] [Reference Citation Analysis]
70 Boeri L, Perottoni S, Izzo L, Giordano C, Albani D. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling. Adv Healthc Mater 2021;10:e2002043. [PMID: 33661580 DOI: 10.1002/adhm.202002043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Heidari Z, Shahrbanian S, Chiu C. Massage therapy as a complementary and alternative approach for people with multiple sclerosis: a systematic review. Disabil Rehabil 2021;:1-12. [PMID: 34338108 DOI: 10.1080/09638288.2021.1949051] [Reference Citation Analysis]
72 Metodiev Y, Braveman F. Anaesthesia and neurological disorders in pregnancy. BJA Educ 2021;21:210-7. [PMID: 34026274 DOI: 10.1016/j.bjae.2021.02.003] [Reference Citation Analysis]
73 Mimpen M, Damoiseaux J, van Doorn W, Rolf L, Muris AH, Hupperts R, van Luijn MM, Gerlach O, Smolders J. Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients. J Neuroimmunol 2021;358:577664. [PMID: 34280843 DOI: 10.1016/j.jneuroim.2021.577664] [Reference Citation Analysis]
74 Askari VR, Baradaran Rahimi V, Tabatabaee SA, Shafiee-nick R. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE). International Immunopharmacology 2019;77:105923. [DOI: 10.1016/j.intimp.2019.105923] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
75 Luetic GG, Menichini ML, Deri N, Steinberg J, Carrá A, Cristiano E, Patrucco L, Curbelo MC, Rojas JI. High birth weight and risk of multiple sclerosis: A multicentre study in Argentina. Mult Scler Relat Disord 2021;47:102628. [PMID: 33220566 DOI: 10.1016/j.msard.2020.102628] [Reference Citation Analysis]
76 Wei W, Ma D, Li L, Zhang L. Progress in the Application of Drugs for the Treatment of Multiple Sclerosis. Front Pharmacol 2021;12:724718. [PMID: 34326775 DOI: 10.3389/fphar.2021.724718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Iandolo R, Bommarito G, Falcitano L, Schiavi S, Piaggio N, Mancardi GL, Casadio M, Inglese M. Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates. Neurorehabil Neural Repair 2020;34:260-70. [PMID: 32028846 DOI: 10.1177/1545968320902126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
78 Kent RD, Kim Y, Chen LM. Oral and Laryngeal Diadochokinesis Across the Life Span: A Scoping Review of Methods, Reference Data, and Clinical Applications. J Speech Lang Hear Res 2021;:1-50. [PMID: 34958599 DOI: 10.1044/2021_JSLHR-21-00396] [Reference Citation Analysis]
79 Buscarinu MC, Fornasiero A, Ferraldeschi M, Romano S, Reniè R, Morena E, Romano C, Pellicciari G, Landi AC, Fagnani C, Salvetti M, Ristori G. Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studies. Neurosci Biobehav Rev 2020;111:194-8. [PMID: 31978439 DOI: 10.1016/j.neubiorev.2020.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Abadi Marand L, Noorizadeh Dehkordi S, Roohi-azizi M, Dadgoo M. Effect of dynamic neuromuscular stabilization on balance and trunk function in people with multiple sclerosis: protocol for a randomized control trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06015-3] [Reference Citation Analysis]
81 Shoeibi A, Khodatars M, Jafari M, Moridian P, Rezaei M, Alizadehsani R, Khozeimeh F, Gorriz JM, Heras J, Panahiazar M, Nahavandi S, Acharya UR. Applications of deep learning techniques for automated multiple sclerosis detection using magnetic resonance imaging: A review. Comput Biol Med 2021;136:104697. [PMID: 34358994 DOI: 10.1016/j.compbiomed.2021.104697] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Choi S, Guo L, Cordeiro MF. Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration. Cells 2021;10:1507. [PMID: 34203793 DOI: 10.3390/cells10061507] [Reference Citation Analysis]
83 Agarwal V, Shah LM, Parsons MS, Boulter DJ, Cassidy RC, Hutchins TA, Jamlik-Omari Johnson, Kendi AT, Khan MA, Liebeskind DS, Moritani T, Ortiz AO, Reitman C, Shah VN, Snyder LA, Timpone VM, Corey AS; Expert Panel on Neurological Imaging. ACR Appropriateness Criteria® Myelopathy: 2021 Update. J Am Coll Radiol 2021;18:S73-82. [PMID: 33958120 DOI: 10.1016/j.jacr.2021.01.020] [Reference Citation Analysis]
84 Yazgan YZ, Tarakcı E, Gungor F, Kurtuncu M. Understanding the impact of cognitive impairment and disease severity on activities of daily living in MS patients with different disability levels. Clin Neurol Neurosurg 2021;200:106398. [PMID: 33310534 DOI: 10.1016/j.clineuro.2020.106398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 McKinney EF, Cuthbertson I, Harris KM, Smilek DE, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC. A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat Commun 2021;12:635. [PMID: 33504809 DOI: 10.1038/s41467-020-20594-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
86 Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM. A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS. Mult Scler Relat Disord 2020;46:102577. [PMID: 33296975 DOI: 10.1016/j.msard.2020.102577] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Ouellette J, Lacoste B. From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum. Front Aging Neurosci 2021;13:749026. [PMID: 34744690 DOI: 10.3389/fnagi.2021.749026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Patel C, Thomas G, Zomorodi N, Zagon IS, McLaughlin PJ. β-endorphin and opioid growth factor as biomarkers of physical ability in multiple sclerosis. Mult Scler Relat Disord 2021;50:102868. [PMID: 33677409 DOI: 10.1016/j.msard.2021.102868] [Reference Citation Analysis]
89 Downton P, Early JO, Gibbs JE. Circadian rhythms in adaptive immunity. Immunology 2020;161:268-77. [PMID: 31837013 DOI: 10.1111/imm.13167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
90 Huynh TLT, Silveira SL, Motl RW. Systematic review of participant characteristics in theory-based bahavior change interventions for physical activity in multiple sclerosis: are we missing those with the greatest potential for lifelong benefits? Disabil Rehabil 2021;:1-20. [PMID: 34334057 DOI: 10.1080/09638288.2021.1954705] [Reference Citation Analysis]
91 Furgiuele A, Cosentino M, Ferrari M, Marino F. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. J Neuroimmune Pharmacol 2021;16:251-69. [PMID: 33492630 DOI: 10.1007/s11481-021-09982-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
92 Klocke S, Hahn N. Multiple sclerosis. Ment Health Clin 2019;9:349-58. [PMID: 31857931 DOI: 10.9740/mhc.2019.11.349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
93 Cunha A, Gaubert A, Latxague L, Dehay B. PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases. Pharmaceutics 2021;13:1042. [PMID: 34371733 DOI: 10.3390/pharmaceutics13071042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kalafatakis I, Patellis A, Charalampopoulos I, Gravanis A, Karagogeos D. The beneficial role of the synthetic microneurotrophin BNN20 in a focal demyelination model. J Neurosci Res 2021;99:1474-95. [PMID: 33583101 DOI: 10.1002/jnr.24809] [Reference Citation Analysis]
95 Perez-carmona N, Gimenez-martinez J, Borrego-honrubia C, Sempere AP. Multiple sclerosis prevalence and incidence in San Vicente del Raspeig, Spain. Multiple Sclerosis and Related Disorders 2019;33:78-81. [DOI: 10.1016/j.msard.2019.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Liu J, Yang X, Pan J, Wei Z, Liu P, Chen M, Liu H. Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease. Front Neurol 2022;12:807646. [DOI: 10.3389/fneur.2021.807646] [Reference Citation Analysis]
97 Chertcoff A, Curbelo MC, Bauer J, Ferrandina F, Martinez A, Steinberg J, Carrá A. Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors. Multiple Sclerosis and Related Disorders 2020;41:102042. [DOI: 10.1016/j.msard.2020.102042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Schriefer D, Haase R, Ness NH, Ziemssen T. Cost of illness in multiple sclerosis by disease characteristics - A review of reviews. Expert Rev Pharmacoecon Outcomes Res 2021;:1-19. [PMID: 34582300 DOI: 10.1080/14737167.2022.1987218] [Reference Citation Analysis]
99 Ayele BA, Wuhib MZ, Zenebe BG, Metaferia GZ. Serum Vitamin D Level among Multiple Sclerosis Patients in the Tropics: Experience from a Private Clinic in Addis Ababa, Ethiopia. Ethiop J Health Sci 2021;31:611-8. [PMID: 34483618 DOI: 10.4314/ejhs.v31i3.18] [Reference Citation Analysis]
100 Chen J, Zhang L, Gan X, Zhang R, He Y, Lv Q, Fu H, Liu X, Miao L. Effects of Retinal Transcription Regulation After GB20 Needling Treatment in Retina With Optic Neuritis. Front Integr Neurosci 2020;14:568449. [PMID: 33117136 DOI: 10.3389/fnint.2020.568449] [Reference Citation Analysis]
101 Adami R, Bottai D. Curcumin and neurological diseases. Nutr Neurosci 2020;:1-21. [PMID: 32441587 DOI: 10.1080/1028415X.2020.1760531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Valentino P, Marnetto F, Martire S, Malucchi S, Bava CI, Popovic M, Bertolotto A. Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. Mult Scler Relat Disord 2021;54:103090. [PMID: 34182224 DOI: 10.1016/j.msard.2021.103090] [Reference Citation Analysis]
103 Akaishi T, Takahashi T, Fujihara K, Misu T, Mugikura S, Abe M, Ishii T, Aoki M, Nakashima I. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis. PLoS One 2020;15:e0231225. [PMID: 32243459 DOI: 10.1371/journal.pone.0231225] [Reference Citation Analysis]
104 Berger AA, Sottosanti ER, Winnick A, Izygon J, Berardino K, Cornett EM, Kaye AD, Varrassi G, Viswanath O, Urits I. Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS). Neurol Int 2021;13:207-23. [PMID: 34069538 DOI: 10.3390/neurolint13020022] [Reference Citation Analysis]
105 Lu G, Liu Z, Wang X, Wang C. Recent Advances in Panax ginseng C.A. Meyer as a Herb for Anti-Fatigue: An Effects and Mechanisms Review. Foods 2021;10:1030. [PMID: 34068545 DOI: 10.3390/foods10051030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Wu M, Zhao M, Wu H, Lu Q. Immune repertoire: Revealing the "real-time" adaptive immune response in autoimmune diseases. Autoimmunity 2021;54:61-75. [PMID: 33650440 DOI: 10.1080/08916934.2021.1887149] [Reference Citation Analysis]
107 Veroni C, Aloisi F. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis. Front Immunol 2021;12:665718. [PMID: 34305896 DOI: 10.3389/fimmu.2021.665718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Zeng Y, Li Z, Zhu H, Gu Z, Zhang H, Luo K. Recent Advances in Nanomedicines for Multiple Sclerosis Therapy. ACS Appl Bio Mater 2020;3:6571-97. [DOI: 10.1021/acsabm.0c00953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Lo MW, Woodruff TM. Complement: Bridging the innate and adaptive immune systems in sterile inflammation. J Leukoc Biol 2020;108:339-51. [PMID: 32182389 DOI: 10.1002/JLB.3MIR0220-270R] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
110 Rodríguez-Regal A, Ramos-Rúa L, Anibarro-García L, Lopez Real AM, Amigo-Jorrín MDC. Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources. Patient Prefer Adherence 2021;15:149-58. [PMID: 33542621 DOI: 10.2147/PPA.S284425] [Reference Citation Analysis]
111 Houen G, Trier NH, Frederiksen JL. Epstein-Barr Virus and Multiple Sclerosis. Front Immunol 2020;11:587078. [PMID: 33391262 DOI: 10.3389/fimmu.2020.587078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
112 Pearse DD, Otero PA, Diaz A, Pan X, Ghosh M. Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Neuroscience 2021;461:140-54. [PMID: 33253822 DOI: 10.1016/j.neuroscience.2020.11.034] [Reference Citation Analysis]
113 García-Muñoz C, Casuso-Holgado MJ, Hernández-Rodríguez JC, Pinero-Pinto E, Palomo-Carrión R, Cortés-Vega MD. Feasibility and safety of an immersive virtual reality-based vestibular rehabilitation programme in people with multiple sclerosis experiencing vestibular impairment: a protocol for a pilot randomised controlled trial. BMJ Open 2021;11:e051478. [PMID: 34810187 DOI: 10.1136/bmjopen-2021-051478] [Reference Citation Analysis]
114 Rupnik M, Baker D, Selwood DL. Oligodendrocytes, BK channels and the preservation of myelin. F1000Res 2021;10:781. [PMID: 34909188 DOI: 10.12688/f1000research.53422.2] [Reference Citation Analysis]
115 Li H, Zheng C, Han J, Zhu J, Liu S, Jin T. PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective. Front Cell Neurosci 2021;15:716747. [PMID: 34381337 DOI: 10.3389/fncel.2021.716747] [Reference Citation Analysis]
116 Metz LM. Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis: . CONTINUUM: Lifelong Learning in Neurology 2019;25:670-88. [DOI: 10.1212/con.0000000000000729] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mimpen M, Muris AH, Rolf L, Gerlach O, Kuhle J, Hupperts R, Smolders J, Damoiseaux J. Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis. Eur J Neurol 2021;28:901-9. [PMID: 33326677 DOI: 10.1111/ene.14680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Wnuk M, Drabik L, Marona M, Szaleniec J, Bryll A, Karcz P, Kolasinska J, Kolasinska M, Ziekiewicz M, Skladzien J, Popiela T, Slowik A. Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies. Ear Nose Throat J 2020;:145561320973777. [PMID: 33236917 DOI: 10.1177/0145561320973777] [Reference Citation Analysis]
119 Greenhalgh AD, David S, Bennett FC. Immune cell regulation of glia during CNS injury and disease. Nat Rev Neurosci 2020;21:139-52. [DOI: 10.1038/s41583-020-0263-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 41.0] [Reference Citation Analysis]
120 Xu J, Zheng Y, Wang L, Liu Y, Wang X, Li Y, Chi G. miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases. Cell Mol Neurobiol 2021. [PMID: 33886036 DOI: 10.1007/s10571-021-01091-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Maqbool M, Zehravi M. Neuroprotective Role of Polyphenols in Treatment of Neurological Disorders: A Review. Interv Pain Med Neuromod 2021;1. [DOI: 10.5812/ipmn.117170] [Reference Citation Analysis]
122 Nichols JM, Kaplan BLF. The CB1 Receptor Differentially Regulates IFN-γ Production In Vitro and in Experimental Autoimmune Encephalomyelitis. Cannabis Cannabinoid Res 2021;6:300-14. [PMID: 33998867 DOI: 10.1089/can.2020.0046] [Reference Citation Analysis]
123 Kallmann BA, Ries S, Kullmann JS, Quint LM, Engelmann U, Chan A. Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Ther Adv Neurol Disord 2021;14:17562864211005588. [PMID: 34046085 DOI: 10.1177/17562864211005588] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Zhang N, Cui Y, Li Y, Mi Y. A Novel Role of Nogo Proteins: Regulating Macrophages in Inflammatory Disease. Cell Mol Neurobiol 2021. [PMID: 34224050 DOI: 10.1007/s10571-021-01124-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Ullah H, Di Minno A, Santarcangelo C, Khan H, Daglia M. Improvement of Oxidative Stress and Mitochondrial Dysfunction by β-Caryophyllene: A Focus on the Nervous System. Antioxidants (Basel) 2021;10:546. [PMID: 33915950 DOI: 10.3390/antiox10040546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
126 Karampoor S, Zahednasab H, Bokharaei-Salim F, Mirzaei R, Mojallal-Tabatabaei Z, Esghaei M, Keyvani H. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol 2020;78:105943. [PMID: 31830622 DOI: 10.1016/j.intimp.2019.105943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
127 Dadouli K, Ntellas P, Anagnostopoulos L, Bonotis K, Dardiotis E, Hadjichristodoulou C. Geography of hospital admissions for multiple sclerosis in Greece. Mult Scler Relat Disord 2021;49:102735. [PMID: 33444957 DOI: 10.1016/j.msard.2021.102735] [Reference Citation Analysis]
128 Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Pohl D. Air pollution and multiple sclerosis risk. Mult Scler Relat Disord 2021;48:102797. [PMID: 33593588 DOI: 10.1016/j.msard.2021.102797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Miller AE. An updated review of teriflunomide's use in multiple sclerosis. Neurodegener Dis Manag 2021;11:387-409. [PMID: 34486382 DOI: 10.2217/nmt-2021-0014] [Reference Citation Analysis]
130 Massarotti C, Sbragia E, Gazzo I, Stigliani S, Inglese M, Anserini P. Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research. J Clin Med 2021;10:5401. [PMID: 34830684 DOI: 10.3390/jcm10225401] [Reference Citation Analysis]
131 Uzunköprü C, Beckmann Y. Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments. EPMA J 2019;10:437-44. [PMID: 31832117 DOI: 10.1007/s13167-019-00179-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
132 Belviranli S, Oltulu P, Uca AU, Gundogan AO, Mirza E, Altas M, Turk N, Oltulu R. Conjunctival impression cytology and tear film parameters in patients with multiple sclerosis. Int Ophthalmol 2021. [PMID: 34599424 DOI: 10.1007/s10792-021-02031-5] [Reference Citation Analysis]
133 Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, Marriott JJ, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study. CMAJ Open 2021;9:E510-21. [PMID: 33990365 DOI: 10.9778/cmajo.20200105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Carl J, Hartung V, Tallner A, Pfeifer K. The Relevance of Competences for a Healthy, Physically Active Lifestyle in Persons with Multiple Sclerosis: a Path Analytical Approach. Behav Med 2021;:1-11. [PMID: 34702133 DOI: 10.1080/08964289.2021.1935437] [Reference Citation Analysis]
135 Walczak-Nowicka ŁJ, Herbet M. Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. Int J Mol Sci 2021;22:9290. [PMID: 34502198 DOI: 10.3390/ijms22179290] [Reference Citation Analysis]
136 Galazka G, Domowicz M, Ewiak-Paszynska A, Jurewicz A. NK Cell Induced T Cell Anergy Depends on GRAIL Expression. Cells 2019;8:E790. [PMID: 31362466 DOI: 10.3390/cells8080790] [Reference Citation Analysis]
137 Rodríguez Mesa XM, Moreno Vergara AF, Contreras Bolaños LA, Guevara Moriones N, Mejía Piñeros AL, Santander González SP. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases. Cannabis Cannabinoid Res 2021;6:196-210. [PMID: 34030476 DOI: 10.1089/can.2020.0183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Yetkin MF, Mirza M. Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients. Journal of Neuroimmunology 2020;346:577307. [DOI: 10.1016/j.jneuroim.2020.577307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Beppi C, Ribeiro Violante I, Scott G, Sandrone S. EEG, MEG and neuromodulatory approaches to explore cognition: Current status and future directions. Brain Cogn 2021;148:105677. [PMID: 33486194 DOI: 10.1016/j.bandc.2020.105677] [Reference Citation Analysis]
140 Bergamaschi R, Tronconi L, Bosone D, Mastretti A, Jommi L, Bassano MA, Turrini R, Benati S, Volpe M, Franzini JM, Allodi S, Mallucci G. Description and preliminary experience with Virtual Visit Assessment (ViVA) during the COVID-19 pandemic, a structured virtual management protocol for patients with multiple sclerosis. Neurol Sci 2021. [PMID: 34131815 DOI: 10.1007/s10072-021-05371-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Amini P, Almasi-Hashiani A, Sahraian MA, Najafi M, Eskandarieh S. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol 2021;21:235. [PMID: 34167483 DOI: 10.1186/s12883-021-02281-x] [Reference Citation Analysis]
142 Masini M, Suleiman M, Novelli M, Marselli L, Marchetti P, De Tata V. Mast Cells and the Pancreas in Human Type 1 and Type 2 Diabetes. Cells 2021;10:1875. [PMID: 34440644 DOI: 10.3390/cells10081875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Mallah K, Couch C, Borucki DM, Toutonji A, Alshareef M, Tomlinson S. Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here? Front Immunol 2020;11:2021. [PMID: 33013859 DOI: 10.3389/fimmu.2020.02021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
144 Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S. Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Sci Rep 2021;11:4087. [PMID: 33602999 DOI: 10.1038/s41598-021-82388-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Midaglia L, Otero S, Baró F, Montalban X, Tintoré M. Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy. Mult Scler. [DOI: 10.1177/1352458520952022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S. The Evolution of Neurofilament Light Chain in Multiple Sclerosis. Front Neurosci 2021;15:642384. [PMID: 33889068 DOI: 10.3389/fnins.2021.642384] [Reference Citation Analysis]
147 Claflin SB, Klekociuk S, Campbell JA, Bessing B, Palmer AJ, van der Mei I, Taylor BV. Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: A cross-sectional study. Mult Scler Relat Disord 2021;54:103158. [PMID: 34329817 DOI: 10.1016/j.msard.2021.103158] [Reference Citation Analysis]
148 Rai SN, Singh P, Steinbusch HWM, Vamanu E, Ashraf G, Singh MP. The Role of Vitamins in Neurodegenerative Disease: An Update. Biomedicines 2021;9:1284. [PMID: 34680401 DOI: 10.3390/biomedicines9101284] [Reference Citation Analysis]
149 Wu Q, Wang Q, Yang J, Martens JW, Mills EA, Saad A, Chilukuri P, Dowling CA, Mao-Draayer Y. Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis. J Cent Nerv Syst Dis 2021;13:11795735211050712. [PMID: 34720605 DOI: 10.1177/11795735211050712] [Reference Citation Analysis]
150 Houen G, Heiden J, Trier NH, Draborg AH, Benros ME, Zinkevičiūtė R, Petraitytė-Burneikienė R, Ciplys E, Slibinskas R, Frederiksen JL. Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis. J Neuroimmunol 2020;346:577314. [PMID: 32682138 DOI: 10.1016/j.jneuroim.2020.577314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Liu B, Yu J. Anti-NLRP3 Inflammasome Natural Compounds: An Update. Biomedicines 2021;9:136. [PMID: 33535473 DOI: 10.3390/biomedicines9020136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Yuksel H, Gursoy GT, Dirik EB, Kenar SG, Bektas H, Yamanel L, Guner HR. Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center. J Clin Neurosci 2021;86:97-102. [PMID: 33775354 DOI: 10.1016/j.jocn.2021.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
153 Fernández RS, Crivelli L, Pedreira ME, Allegri RF, Correale J. Computational basis of decision-making impairment in multiple sclerosis. Mult Scler 2021;:13524585211059308. [PMID: 34931933 DOI: 10.1177/13524585211059308] [Reference Citation Analysis]
154 Saito LB, Fernandes JP, Smith MJ, Doan MAL, Branton WG, Schmitt LM, Wuest M, Monaco MC, Major EO, Wuest F, Power C. Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis. Glia 2021;69:216-29. [PMID: 32882086 DOI: 10.1002/glia.23896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
155 Blair HA. Dimethyl Fumarate: A Review in Relapsing-Remitting MS. Drugs 2019;79:1965-76. [PMID: 31784875 DOI: 10.1007/s40265-019-01229-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
156 Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Metformin as a Potential Agent in the Treatment of Multiple Sclerosis. Int J Mol Sci 2020;21:E5957. [PMID: 32825027 DOI: 10.3390/ijms21175957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
157 Feige J, Moser T, Bieler L, Schwenker K, Hauer L, Sellner J. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats. Nutrients 2020;12:E783. [PMID: 32188044 DOI: 10.3390/nu12030783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
158 Westergaard K, Skovgaard L, Magyari M, Kristiansen M. Patient perspectives on patient-reported outcomes in multiple sclerosis treatment trajectories: A qualitative study of why, what, and how? Mult Scler Relat Disord 2021;58:103475. [PMID: 34995975 DOI: 10.1016/j.msard.2021.103475] [Reference Citation Analysis]
159 Wang H. MicroRNAs, Multiple Sclerosis, and Depression. Int J Mol Sci 2021;22:7802. [PMID: 34360568 DOI: 10.3390/ijms22157802] [Reference Citation Analysis]
160 Plowman RS, Varma H. Prognostic factors in Tumefactive demyelinating lesions: A retrospective study. J Neurol Sci 2021;428:117591. [PMID: 34333380 DOI: 10.1016/j.jns.2021.117591] [Reference Citation Analysis]
161 Tonetti L, Camilli F, Giovagnoli S, Natale V, Lugaresi A. A Pilot Study of 24-h Motor Activity Patterns in Multiple Sclerosis: Pre-Planned Follow-Up at 2 Years. Clocks Sleep 2021;3:366-76. [PMID: 34203507 DOI: 10.3390/clockssleep3030023] [Reference Citation Analysis]
162 Schriefer D, Ness NH, Haase R, Ziemssen T. Gender disparities in health resource utilization in patients with relapsing-remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients. Ther Adv Neurol Disord 2020;13:1756286420960274. [PMID: 33178335 DOI: 10.1177/1756286420960274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Damasiewicz-Bodzek A, Łabuz-Roszak B, Kumaszka B, Tadeusiak B, Tyrpień-Golder K. The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients. Brain Sci 2021;11:1021. [PMID: 34439640 DOI: 10.3390/brainsci11081021] [Reference Citation Analysis]
164 Naser Moghadasi A, Poursadeghfard M, Kazemi T, Hosseini S. Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis. Iran J Otorhinolaryngol 2020;32:249-53. [PMID: 32850514 DOI: 10.22038/ijorl.2020.40858.2334] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Moorman CD, Bastian AG, DeOca KB, Mannie MD. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE). J Neuroinflammation 2020;17:180. [PMID: 32522287 DOI: 10.1186/s12974-020-01856-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Tian Y, Fu C, Wu Y, Lu Y, Liu X, Zhang Y. Central Nervous System Cell-Derived Exosomes in Neurodegenerative Diseases. Oxid Med Cell Longev 2021;2021:9965564. [PMID: 34336127 DOI: 10.1155/2021/9965564] [Reference Citation Analysis]
167 Al-Abdi L, Al Murshedi F, Elmanzalawy A, Al Habsi A, Helaby R, Ganesh A, Ibrahim N, Patel N, Alkuraya FS. CNP deficiency causes severe hypomyelinating leukodystrophy in humans. Hum Genet 2020;139:615-22. [PMID: 32128616 DOI: 10.1007/s00439-020-02144-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
168 Misrielal C, Mauthe M, Reggiori F, Eggen BJL. Autophagy in Multiple Sclerosis: Two Sides of the Same Coin. Front Cell Neurosci 2020;14:603710. [PMID: 33328897 DOI: 10.3389/fncel.2020.603710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Ahmadi A, Gispert JD, Navarro A, Vilor-Tejedor N, Sadeghi I. Single-cell Transcriptional Changes in Neurodegenerative Diseases. Neuroscience 2021:S0306-4522(21)00544-3. [PMID: 34748859 DOI: 10.1016/j.neuroscience.2021.10.025] [Reference Citation Analysis]
170 Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Mult Scler Relat Disord 2021;50:102801. [PMID: 33636616 DOI: 10.1016/j.msard.2021.102801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, Alexaki VI. Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol 2019;55:100788. [PMID: 31513776 DOI: 10.1016/j.yfrne.2019.100788] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
172 Alolayet D, Alobaid F, Ahmed ME, Waheed K. Multiple Sclerosis Masquerading as Post Septorhinoplasty Complication: A Case Report. Cureus 2021;13:e19591. [PMID: 34956744 DOI: 10.7759/cureus.19591] [Reference Citation Analysis]
173 Takenaka S, Fujisawa T, Ichijo H. Apoptosis signal-regulating kinase 1 (ASK1) as a therapeutic target for neurological diseases. Expert Opin Ther Targets 2020;24:1061-4. [PMID: 32930624 DOI: 10.1080/14728222.2020.1821648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Patel J, Prasad R, Bryant C, Connolly H, Teasdale B, Moosajee S. Multiple sclerosis and its impact on dental care. Br Dent J 2021;231:281-6. [PMID: 34508197 DOI: 10.1038/s41415-021-3333-0] [Reference Citation Analysis]
175 Ruggieri M, Gargano CD, Ferretta A, Manni A, Capacchione A, Frigeri A, Iaffaldano P, Trojano M, Paolicelli D. Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy. Brain Sci 2020;10:E548. [PMID: 32823496 DOI: 10.3390/brainsci10080548] [Reference Citation Analysis]
176 Pöttler M, Cicha I, Unterweger H, Janko C, Friedrich RP, Alexiou C. Nanoparticles for regenerative medicine. Nanomedicine (Lond) 2019;14:1929-33. [PMID: 31370757 DOI: 10.2217/nnm-2019-0162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
177 Tang L, Wei X, Li T, Chen Y, Dai Z, Lu C, Zheng G. Emerging Perspectives of RNA N 6-methyladenosine (m6A) Modification on Immunity and Autoimmune Diseases. Front Immunol 2021;12:630358. [PMID: 33746967 DOI: 10.3389/fimmu.2021.630358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
178 Muri L, Leppert D, Grandgirard D, Leib SL. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Cell Mol Life Sci 2019;76:3097-116. [PMID: 31172218 DOI: 10.1007/s00018-019-03174-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
179 Mitchell RE, Bates K, Wootton RE, Harroud A, Richards JB, Davey Smith G, Munafò MR. Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study. PLoS Biol 2020;18:e3000973. [PMID: 33253141 DOI: 10.1371/journal.pbio.3000973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
180 Khan H, Sami MB, Litvak V. The utility of Magnetoencephalography in multiple sclerosis - A systematic review. Neuroimage Clin 2021;32:102814. [PMID: 34537682 DOI: 10.1016/j.nicl.2021.102814] [Reference Citation Analysis]
181 Marta M, Baker D, Creeke P, Pryce G, Gnanapavan S, Giovannoni G. Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case report. Mult Scler Relat Disord 2021;56:103284. [PMID: 34624642 DOI: 10.1016/j.msard.2021.103284] [Reference Citation Analysis]
182 Severa M, Rizzo F, Srinivasan S, Di Dario M, Giacomini E, Buscarinu MC, Cruciani M, Etna MP, Sandini S, Mechelli R, Farina A, Trivedi P, Hertzog PJ, Salvetti M, Farina C, Coccia EM. A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis. J Autoimmun 2019;101:1-16. [PMID: 31047767 DOI: 10.1016/j.jaut.2019.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
183 Segal BM. The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models. J Clin Med 2019;8:E120. [PMID: 30669462 DOI: 10.3390/jcm8010120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
184 Dziedzic A, Miller E, Saluk-Bijak J, Niwald M, Bijak M. The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y12 Pathway in Multiple Sclerosis. Int J Mol Sci 2021;22:6572. [PMID: 34207429 DOI: 10.3390/ijms22126572] [Reference Citation Analysis]
185 Zhang R, Liu J, Xu B, Wu Y, Liang S, Yuan Q. Cornuside alleviates experimental autoimmune encephalomyelitis by inhibiting Th17 cell infiltration into the central nervous system. J Zhejiang Univ Sci B 2021;22:421-30. [PMID: 33973423 DOI: 10.1631/jzus.B2000771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Etemadifar M, Salari M, Esnaashari A, Ghazanfaripoor F, Sayahi F, Akhavan Sigari A, Sedaghat N. Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors. Mult Scler Relat Disord 2022;58:103488. [PMID: 34999375 DOI: 10.1016/j.msard.2022.103488] [Reference Citation Analysis]
187 Fantuzzi L, Tagliamonte M, Gauzzi MC, Lopalco L. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. Cell Mol Life Sci 2019;76:4869-86. [PMID: 31377844 DOI: 10.1007/s00018-019-03255-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
188 Miclea A, Bagnoud M, Chan A, Hoepner R. A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Front Immunol 2020;11:781. [PMID: 32435244 DOI: 10.3389/fimmu.2020.00781] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
189 Lagisquet J, Zuber K, Gramberg T. Recognize Yourself-Innate Sensing of Non-LTR Retrotransposons. Viruses 2021;13:94. [PMID: 33445593 DOI: 10.3390/v13010094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Newland P, Bettencourt BA, Schares S, Hendricks-Ferguson V. Testing of Journal Writing for Symptom Concordance in Adults with Multiple Sclerosis. Int J MS Care 2021;23:157-61. [PMID: 34483754 DOI: 10.7224/1537-2073.2019-108] [Reference Citation Analysis]
191 Brys R, Gibson K, Poljak T, Van Der Plas S, Amantini D. Discovery and development of ASK1 inhibitors. Prog Med Chem 2020;59:101-79. [PMID: 32362327 DOI: 10.1016/bs.pmch.2020.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
192 Laíns I, Wang JC, Cui Y, Katz R, Vingopoulos F, Staurenghi G, Vavvas DG, Miller JW, Miller JB. Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Prog Retin Eye Res 2021;:100951. [PMID: 33516833 DOI: 10.1016/j.preteyeres.2021.100951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
193 Verduyn C, Bjerke M, Duerinck J, Engelborghs S, Peers K, Versijpt J, D'haeseleer M. CSF and Blood Neurofilament Levels in Athletes Participating in Physical Contact Sports: A Systematic Review. Neurology 2021;96:705-15. [PMID: 33637627 DOI: 10.1212/WNL.0000000000011750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
194 Brisset JC, Vukusic S, Cotton F; Imaging Group of the 'Observatoire francais de la sclérose en plaques'. Update on brain MRI for the diagnosis and follow-up of MS patients. Presse Med 2021;50:104067. [PMID: 33989722 DOI: 10.1016/j.lpm.2021.104067] [Reference Citation Analysis]
195 Nguemeni C, Hiew S, Kögler S, Homola GA, Volkmann J, Zeller D. Split-Belt Training but Not Cerebellar Anodal tDCS Improves Stability Control and Reduces Risk of Fall in Patients with Multiple Sclerosis. Brain Sciences 2022;12:63. [DOI: 10.3390/brainsci12010063] [Reference Citation Analysis]
196 Yang C, Wu M, You M, Chen Y, Luo M, Chen Q. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther 2021;12:103. [PMID: 33541422 DOI: 10.1186/s13287-021-02158-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
197 Chen Z, Wu H, Zhang M. Long non-coding RNA: An underlying bridge linking neuroinflammation and central nervous system diseases. Neurochem Int 2021;148:105101. [PMID: 34139298 DOI: 10.1016/j.neuint.2021.105101] [Reference Citation Analysis]
198 Gratpain V, Mwema A, Labrak Y, Muccioli GG, van Pesch V, des Rieux A. Extracellular vesicles for the treatment of central nervous system diseases. Adv Drug Deliv Rev 2021;174:535-52. [PMID: 33991589 DOI: 10.1016/j.addr.2021.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Brier MR, Snyder AZ, Tanenbaum A, Rudick RA, Fisher E, Jones S, Shimony JS, Cross AH, Benzinger TLS, Naismith RT. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability. Ann Clin Transl Neurol 2021;8:1096-109. [PMID: 33943045 DOI: 10.1002/acn3.51354] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Alcover-Sanchez B, Garcia-Martin G, Wandosell F, Cubelos B. R-Ras GTPases Signaling Role in Myelin Neurodegenerative Diseases. Int J Mol Sci 2020;21:E5911. [PMID: 32824627 DOI: 10.3390/ijms21165911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Imamura M, Higuchi O, Maeda Y, Mukaino A, Ueda M, Matsuo H, Nakane S. Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity. Int J Mol Sci 2020;21:E9632. [PMID: 33348803 DOI: 10.3390/ijms21249632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Calabrò RS. When Healthcare Providers do not Ask, Patients Rarely Tell: The Importance of Sexual Counselling in Multiple Sclerosis. J Natl Med Assoc 2019;111:682-7. [PMID: 31155408 DOI: 10.1016/j.jnma.2019.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Mechelli R, Umeton R, Manfrè G, Romano S, Buscarinu MC, Rinaldi V, Bellucci G, Bigi R, Ferraldeschi M, Salvetti M, Ristori G. Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis. Genes (Basel) 2020;11:E97. [PMID: 31947683 DOI: 10.3390/genes11010097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Torpil B, Ekici Çağlar G, Bumin G, Pekçetin S. Validity and Reliability of the Turkish Canadian Occupational Performance Measure (COPM-TR) for People with Multiple Sclerosis. Occup Ther Health Care 2021;35:306-17. [PMID: 34126836 DOI: 10.1080/07380577.2021.1933673] [Reference Citation Analysis]
205 Kristensen MK, Christensen T. Regulation of the expression of human endogenous retroviruses: elements in fetal development and a possible role in the development of cancer and neurological diseases. APMIS 2021;129:241-53. [PMID: 33683784 DOI: 10.1111/apm.13130] [Reference Citation Analysis]
206 Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, Perlman S. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proc Natl Acad Sci U S A 2020;117:15902-10. [PMID: 32571951 DOI: 10.1073/pnas.2003432117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
207 Pasca S, Jurj A, Petrushev B, Tomuleasa C, Matei D. MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. Front Immunol 2020;11:625. [PMID: 32351507 DOI: 10.3389/fimmu.2020.00625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
208 Yıldız Z, Doymaz F, Özden F. The reliability and validity of the Turkish version of the apraxia screen of TULIA in multiple sclerosis patients. Disabil Rehabil 2021;:1-6. [PMID: 34898347 DOI: 10.1080/09638288.2021.2003447] [Reference Citation Analysis]
209 Van Kaer L, Postoak JL, Wang C, Yang G, Wu L. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Cell Mol Immunol. 2019;16:531-539. [PMID: 30874627 DOI: 10.1038/s41423-019-0221-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
210 Cocco E, Fadda P. Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil. Exp Neurol 2021;347:113906. [PMID: 34710403 DOI: 10.1016/j.expneurol.2021.113906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Reyes S, Suarez S, Allen-Philbey K, Thomson A, Giovannoni G. The impact of social capital on patients with multiple sclerosis. Acta Neurol Scand 2020;142:58-65. [PMID: 32189325 DOI: 10.1111/ane.13244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
212 Del Pilar Pérez-Trujillo M, González-Platas M, Pérez-Martín MY, Revert-Gironés MC, González-Platas J. Dry needling for treating spasticity in multiple sclerosis. J Phys Ther Sci 2021;33:505-10. [PMID: 34219954 DOI: 10.1589/jpts.33.505] [Reference Citation Analysis]
213 Chase Huizar C, Raphael I, Forsthuber TG. Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis. Cell Immunol 2020;358:104219. [PMID: 33039896 DOI: 10.1016/j.cellimm.2020.104219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
214 Midaglia L, Sastre-garriga J, Pappolla A, Quibus L, Carvajal R, Vidal-jordana A, Arrambide G, Río J, Comabella M, Nos C, Castilló J, Galan I, Rodríguez-acevedo B, Auger C, Tintoré M, Montalban X, Rovira À. The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia. Mult Scler 2021;27:913-21. [DOI: 10.1177/1352458520988148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
215 Shokati A, Naser Moghadasi A, Nikbakht M, Sahraian MA, Mousavi SA, Ai J. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis. Stem Cell Res Ther 2021;12:400. [PMID: 34256857 DOI: 10.1186/s13287-021-02477-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R, Creta A, Cecchi G, Cola G, Nicoletti CG, Cortese A, De Giglio L, Tartaglia M, Crisafulli SG, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation. Mult Scler 2021;27:1939-47. [PMID: 33565913 DOI: 10.1177/1352458520987541] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Sahin Ediz S, Atalay B, Aydin Canturk I, Kabaalioglu A. Assessment of the optic nerve, optic disc, and perineural area using shear-wave elastography in patients with multiple sclerosis. Int J Clin Pract 2021;:e14736. [PMID: 34392588 DOI: 10.1111/ijcp.14736] [Reference Citation Analysis]
218 Jandric D, Doshi A, Scott R, Paling D, Rog D, Chataway J, Schoonheim M, Parker G, Muhlert N. A systematic review of resting state functional MRI connectivity changes and cognitive impairment in multiple sclerosis. Brain Connect 2021. [PMID: 34382408 DOI: 10.1089/brain.2021.0104] [Reference Citation Analysis]
219 Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P. Leptin levels are associated with multiple sclerosis risk. Mult Scler 2021;27:19-27. [PMID: 32028836 DOI: 10.1177/1352458520905033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
220 Krüger K, Fricke LM, Dilger EM, Thiele A, Schaubert K, Hoekstra D, Heidenreich F, Brütt AL, Stahmeyer JT, Stahmann A, Röper AL, Kubiak KP, Hemmerling M, Grau A, Eichstädt K, Behrens S, Krauth C. How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV). PLoS One 2021;16:e0259855. [PMID: 34762697 DOI: 10.1371/journal.pone.0259855] [Reference Citation Analysis]
221 Kapadia A, Dmytriw AA. Multiple sclerosis is a systemic venous vasculopathy: A single unifying mechanism. Med Hypotheses 2020;140:109645. [PMID: 32135448 DOI: 10.1016/j.mehy.2020.109645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Baker D, Asardag AN, Quinn OA, Efimov A, Kang AS. Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis. Hum Antibodies 2021. [PMID: 34397407 DOI: 10.3233/HAB-210453] [Reference Citation Analysis]
223 Kelly RR, Sidles SJ, LaRue AC. Effects of Neurological Disorders on Bone Health. Front Psychol 2020;11:612366. [PMID: 33424724 DOI: 10.3389/fpsyg.2020.612366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
224 Lassiter G, Melancon C, Rooney T, Murat AM, Kaye JS, Kaye AM, Kaye RJ, Cornett EM, Kaye AD, Shah RJ, Viswanath O, Urits I. Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Neurol Int 2020;12:89-108. [PMID: 33287177 DOI: 10.3390/neurolint12030016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
225 Pérez-Pérez S, Domínguez-Mozo MI, García-Martínez MÁ, García-Frontini MC, Villarrubia N, Costa-Frossard L, Villar LM, Arroyo R, Álvarez-Lafuente R. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression. Front Immunol 2021;12:798003. [PMID: 34912348 DOI: 10.3389/fimmu.2021.798003] [Reference Citation Analysis]
226 Leitzen E, Jin W, Herder V, Beineke A, Elmarabet SA, Baumgärtner W, Hansmann F. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease. Int J Mol Sci 2019;20:E989. [PMID: 30823515 DOI: 10.3390/ijms20040989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
227 D'Amico E, Zanghì A, Gastaldi M, Patti F, Zappia M, Franciotta D. Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives. Autoimmun Rev 2019;18:665-72. [PMID: 31059839 DOI: 10.1016/j.autrev.2019.05.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
228 Klimko CV, Sanders JM, Johns ML. Probable Encephalopathy and Spasticity in a Multiple Sclerosis Patient Following Carbapenem Administration: A Case Report and Brief Literature Review. J Pharm Pract 2021;:8971900211063277. [PMID: 34958618 DOI: 10.1177/08971900211063277] [Reference Citation Analysis]
229 Moral-Torres E, Fernández-Fernández Ó, Caballero-Martínez F, Carrascal-Rueda P, Monge-Martín D, Campos-Lucas FJ. Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in Spain. Mult Scler Relat Disord 2021;56:103186. [PMID: 34455136 DOI: 10.1016/j.msard.2021.103186] [Reference Citation Analysis]
230 Zhao RZ, Zhang GX, Zhang WT, Yu WJ, Du L, Toledo MC, Olivera Leal IR, O'Farrill ZL, Izquierdo G. Ocular manifestations of multiple sclerosis in patients from three countries: A Web-based survey. Eur J Ophthalmol 2021;:11206721211069457. [PMID: 34939452 DOI: 10.1177/11206721211069457] [Reference Citation Analysis]
231 Claflin SB, Campbell JA, Doherty K, Farrow M, Bessing B, Taylor BV. Evaluating Course Completion, Appropriateness, and Burden in the Understanding Multiple Sclerosis Massive Open Online Course: Cohort Study. J Med Internet Res 2021;23:e21681. [PMID: 34878985 DOI: 10.2196/21681] [Reference Citation Analysis]
232 Savinetti I, Papagna A, Foti M. Human Monocytes Plasticity in Neurodegeneration. Biomedicines 2021;9:717. [PMID: 34201693 DOI: 10.3390/biomedicines9070717] [Reference Citation Analysis]
233 Saposnik G, Bueno-Gil G, Sempere ÁP, Rodríguez-Antigüedad A, Del Río B, Baz M, Terzaghi M, Ballesteros J, Maurino J. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol. Front Neurol 2021;12:675520. [PMID: 34234734 DOI: 10.3389/fneur.2021.675520] [Reference Citation Analysis]
234 Dupuis ML, Pagano MT, Pierdominici M, Ortona E. The role of vitamin D in autoimmune diseases: could sex make the difference? Biol Sex Differ 2021;12:12. [PMID: 33436077 DOI: 10.1186/s13293-021-00358-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
235 Morawska J, Niebudek-Bogusz E, Stasiołek M, Świderek-Matysiak M, Pietruszewska W. Speech Pathology-Specific Questionnaire for Persons with Multiple Sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential. Mult Scler Relat Disord 2021;49:102796. [PMID: 33540280 DOI: 10.1016/j.msard.2021.102796] [Reference Citation Analysis]
236 Schriefer D, Haase R, Ettle B, Ziemssen T. Patient- versus physician-reported relapses in multiple sclerosis: insights from a large observational study. Eur J Neurol 2020;27:2531-8. [PMID: 32643851 DOI: 10.1111/ene.14432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
237 Barros GMC, Oliveira BES, Oliveira GJ, Silva RKP, Cardoso TN, Maia SB. Disease Progression and Obstetric Outcomes of Women with Multiple Sclerosis at a Reference Center in Northeastern Brazil. Rev Bras Ginecol Obstet 2021;43:165-71. [PMID: 33860499 DOI: 10.1055/s-0040-1722157] [Reference Citation Analysis]
238 Teixeira N, Sant'anna M, Giardini A, Araujo L, Fonseca L, Basso A, Cury Y, Picolo G. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG35-55-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Brain, Behavior, and Immunity 2020;84:253-68. [DOI: 10.1016/j.bbi.2019.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
239 Doelman W, Marqvorsen MHS, Chiodo F, Bruijns SCM, van der Marel GA, van Kooyk Y, van Kasteren SI, Araman C. Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC-SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis. Chemistry 2021;27:2742-52. [PMID: 33090600 DOI: 10.1002/chem.202004076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
240 Ge F, Huo Z, Li C, Wang R, Wang R, Liu Y, Chen J, Lu Y, Wen Y, Jiang Y, Peng H, Wu X, Liang H, He J, Liang W. Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis. Mult Scler Relat Disord 2021;51:102927. [PMID: 33812221 DOI: 10.1016/j.msard.2021.102927] [Reference Citation Analysis]
241 Becker A, Abuazab M, Schwiertz A, Walter S, Faßbender KC, Fousse M, Unger MM. Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products? Auto Immun Highlights 2021;12:7. [PMID: 33827656 DOI: 10.1186/s13317-021-00149-1] [Reference Citation Analysis]
242 Lin YC, Hsu CH, Wang PN, Lin CP, Chang LH. The Relationship Between Zebrin Expression and Cerebellar Functions: Insights From Neuroimaging Studies. Front Neurol 2020;11:315. [PMID: 32390933 DOI: 10.3389/fneur.2020.00315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Barros Ribeiro da Silva V, Porcionatto M, Toledo Ribas V. The Rise of Molecules Able To Regenerate the Central Nervous System. J Med Chem 2020;63:490-511. [PMID: 31518122 DOI: 10.1021/acs.jmedchem.9b00863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
244 Amato A, Messina G, Feka K, Genua D, Ragonese P, Kostrzewa-Nowak D, Fischetti F, Iovane A, Proia P. Taopatch® combined with home-based training protocol to prevent sedentary lifestyle and biochemical changes in MS patients during COVID-19 pandemic. Eur J Transl Myol 2021;31. [PMID: 34498450 DOI: 10.4081/ejtm.2021.9877] [Reference Citation Analysis]
245 Ostojic SM. Creatine and multiple sclerosis. Nutr Neurosci 2020;:1-8. [PMID: 32912105 DOI: 10.1080/1028415X.2020.1819108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Moussa M, Abou Chakra M, Papatsoris AG, Dabboucy B, Hsieh M, Dellis A, Fares Y. Perspectives on urological care in multiple sclerosis patients. Intractable Rare Dis Res 2021;10:62-74. [PMID: 33996350 DOI: 10.5582/irdr.2021.01029] [Reference Citation Analysis]
247 Joodi Khanghah O, Nourazarian A, Khaki-Khatibi F, Nikanfar M, Laghousi D, Vatankhah AM, Moharami S. Evaluation of the Diagnostic and Predictive Value of Serum Levels of ANT1, ATG5, and Parkin in Multiple Sclerosis. Clin Neurol Neurosurg 2020;197:106197. [PMID: 32890892 DOI: 10.1016/j.clineuro.2020.106197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
248 Schriefer D, Haase R, Kullmann JS, Ziemssen T. Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study. Patient Prefer Adherence 2020;14:869-80. [PMID: 32546981 DOI: 10.2147/PPA.S248272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
249 Larsen JL, Schäfer J, Nielsen HH, Vestergaard Rasmussen P. Qualitative factors shaping MS patients' experiences of infusible disease-modifying drugs: a critical incident technique analysis. BMJ Open 2020;10:e037701. [PMID: 32819993 DOI: 10.1136/bmjopen-2020-037701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
250 Mimpen M, Rolf L, Muris AH, Gerlach O, Poelmans G, Hupperts R, Smolders J, Damoiseaux J. NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis. J Neuroimmunol 2021;353:577499. [PMID: 33529846 DOI: 10.1016/j.jneuroim.2021.577499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Amuno S, Bedos L, Kodzhahinchev V, Shekh K, Niyogi S, Grahn B. Comparative study of arsenic toxicosis and ocular pathology in wild muskrats (Ondatra zibethicus) and red squirrels (Tamiasciurus hudsonicus) breeding in arsenic contaminated areas of Yellowknife, Northwest Territories (Canada). Chemosphere 2020;248:126011. [PMID: 32028161 DOI: 10.1016/j.chemosphere.2020.126011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Imas DM, Duncan EL, Tay ET. Vertical nystagmus as isolated presentation in a patient with new diagnosis of multiple sclerosis. Am J Emerg Med 2021;39:259.e1-3. [PMID: 32798013 DOI: 10.1016/j.ajem.2020.07.037] [Reference Citation Analysis]
253 Jacob L, Smith L, Koyanagi A, Haro JM, Konrad M, Tanislav C, Kostev K. Is there an association between multiple sclerosis and osteoarthritis in Germany? A retrospective cohort study of 8,600 patients from Germany. Mult Scler J Exp Transl Clin 2021;7:20552173211022784. [PMID: 34262785 DOI: 10.1177/20552173211022784] [Reference Citation Analysis]
254 Ahmadi A, De Toma I, Vilor-Tejedor N, Eftekhariyan Ghamsari MR, Sadeghi I. Transposable elements in brain health and disease. Ageing Res Rev 2020;64:101153. [PMID: 32977057 DOI: 10.1016/j.arr.2020.101153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
255 Desu HL, Plastini M, Illiano P, Bramlett HM, Dietrich WD, de Rivero Vaccari JP, Brambilla R, Keane RW. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis. J Neuroinflammation 2020;17:143. [PMID: 32366256 DOI: 10.1186/s12974-020-01826-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
256 Graham JJ, Longhi MS, Heneghan MA. T helper cell immunity in pregnancy and influence on autoimmune disease progression. J Autoimmun 2021;121:102651. [PMID: 34020252 DOI: 10.1016/j.jaut.2021.102651] [Reference Citation Analysis]
257 Ma T, Wang F, Xu S, Huang JH. Meningeal immunity: Structure, function and a potential therapeutic target of neurodegenerative diseases. Brain Behav Immun 2021;93:264-76. [PMID: 33548498 DOI: 10.1016/j.bbi.2021.01.028] [Reference Citation Analysis]
258 Rezaee M, Keshavarz K, Izadi S, Jafari A, Ravangard R. Economic burden of multiple sclerosis: a cross-sectional study in Iran. Health Econ Rev 2022;12:2. [PMID: 34981265 DOI: 10.1186/s13561-021-00350-y] [Reference Citation Analysis]
259 Park J, Choi SW, Cha BG, Kim J, Kang SJ. Alternative Activation of Macrophages through Interleukin-13-Loaded Extra-Large-Pore Mesoporous Silica Nanoparticles Suppresses Experimental Autoimmune Encephalomyelitis. ACS Biomater Sci Eng 2021;7:4446-53. [PMID: 34435775 DOI: 10.1021/acsbiomaterials.1c00946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Walsh AD, Nguyen LT, Binder MD. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology. ASN Neuro 2021;13:1759091420981182. [PMID: 33517686 DOI: 10.1177/1759091420981182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Sánchez-Tejeda JF, Sánchez-Ruiz JF, Salazar JR, Loza-Mejía MA. A Definition of "Multitargeticity": Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis. Front Chem 2020;8:176. [PMID: 32232029 DOI: 10.3389/fchem.2020.00176] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Doosti-Irani A, Tamtaji OR, Mansournia MA, Ghayour-Mobarhan M, Ferns G, Daneshvar Kakhaki R, Rezaei Shahmirzadi A, Asemi Z. The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials. Clin Neurol Neurosurg 2019;187:105564. [PMID: 31669929 DOI: 10.1016/j.clineuro.2019.105564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]